15 Feb 2011: NorDiag today announces that the Company's portfolio of sample preparation kits for the Arrow instrument in the Life Science market is available for sale to hospitals, laboratories and research institutes.  The portfolio consists of three different applications; Arrow RNA, Arrow DNA and Arrow cell separation.

In addition, NorDiag has a portfolio of CE IVD marked sample preparation kits (DNA from stool, Viral NA, Bugs & Beads and DNA from blood) that also can be sold to the Life Science market. 

NorDiag is the first company in the market with an instrument that can offer an automated solution for both isolation of nucleic acids and cells. This combined with an affordable desk top solution is a strong selling point in the life science market. 

"The portfolio opens up the USD 18 billion Life Science market. The applications and the unique flexibility of the instrument drives the sales and as such, NorDiag has a very good strategic position to enter the Life Science market, explains CEO Mårten Wigstøl and adds, "NorDiag does not have a sales channel to sell in this market and will search for a distribution partner".

NorDiags Arrow instrument has the capacity of up to 10 000 isolations per year.
 
 
Contact: CEO Mårten Wigstøl               Phone. +47 911 65775
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 40 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information - www.nordiag.com.

Read the Notice in Norwegian here